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Introduction
============

The ER is a dynamic protein-folding compartment that can be expanded according to the demands placed upon the exocytic pathway. This is exemplified by the highly developed ER network present in specialized secretory cells such as insulin-producing β cells of the pancreas and antibody-secreting plasma cells. Yet, the molecular mechanisms that coordinate the synthesis of protein and lipid components necessary for ER biogenesis remain poorly understood.

Homeostasis of the ER is regulated in large part by the unfolded protein response (UPR), a complex signaling system emanating from the ER membrane that regulates translation and transcription in response to increased demands on the protein folding capacity of the ER ([@bib22]). One branch of the UPR is directed by the ER membrane-bound activating transcription factor 6α and 6β (ATF6α/β). Regulated intramembrane proteolysis releases the soluble cytosolic domains of ATF6α/β to function as basic leucine zipper transcription factors that up-regulate expression of various ER resident chaperones and folding enzymes ([@bib9], [@bib10]).

A second branch of the UPR that induces transcription involves X-box binding protein 1 (XBP1). The ER transmembrane kinase/endoribonucleases IRE1α (expressed ubiquitously; [@bib25]) and β (expressed in gut epithelium; [@bib27]) initiate a novel UPR-mediated mRNA splicing mechanism that modifies *XBP1* transcripts to encode a potent basic leucine zipper transcription factor, XBP1(S). In contrast, unspliced *XBP1* mRNA encodes a basic leucine zipper protein, XBP1(U), that lacks transactivation activity and is more labile than XBP1(S) ([@bib30]; [@bib3]). Genes identified as targets of XBP1(S) encode proteins that function in the ER ([@bib17]; [@bib31]). Thus, like ATF6α/β, the IRE1-XBP1 pathway appears to enhance the ability of the ER to properly handle an increased load of client proteins.

The differentiation of B-lymphocytes into antibody-secreting cells requires *XBP1* and its modulation by UPR-mediated splicing ([@bib13]), and pancreatic tissue exhibits robust splicing of *XBP1* mRNA ([@bib14]). Furthermore, synthesis of phosphatidylcholine (PtdCho), the predominant phospholipid in mammalian ER membranes ([@bib18]), elevates in B-cells differentiating in response to lipopolysaccharide ([@bib21]). PtdCho biosynthesis also increases in macrophages subjected to free cholesterol loading ([@bib24]), another example of physiologic UPR activation ([@bib6]). Therefore, UPR activation correlates with the presence of an elaborate ER in specialized secretory cells and with induction of phospholipid biosynthesis, but a molecular mechanism linking the UPR to ER biogenesis has not been elucidated.

Given the roles of the UPR in maintenance of ER homeostasis, we hypothesized that the UPR might regulate overall ER abundance. Here, we report that enforced expression of a single transcription factor, XBP1(S), is sufficient to induce PtdCho biosynthesis, elevate the level of membrane phospholipids, and trigger expansion of the ER in fibroblasts. These data suggest that XBP1(S) regulates ER biogenesis, revealing another means by which cells use the UPR to cope with increased demands on the exocytic pathway.

Results and discussion
======================

Effect of XBP1(S) on phospholipid biosynthesis and ER expansion
---------------------------------------------------------------

To determine whether mammalian UPR transcriptional activators regulate phospholipid biosynthesis, we transduced NIH-3T3 fibroblasts with retroviral vectors encoding either XBP1(U), XBP1(S), or a constitutively active form of ATF6α (ATF6α(373); Yoshida et al., 2000). Flow cytometric assessment of GFP, expressed via the bicistronic mRNA encoded by the retroviral vectors, revealed ≥95% transduction efficiency for all retroviral constructs tested in NIH-3T3 cells (see online supplemental material, available at <http://www.jcb.org/cgi/content/full/jcb.200406136/DC1>). As expected, ATF6α(373) induced expression of immunoglobulin heavy chain binding protein (BiP) and the disulfide-isomerase-like protein ERp72, two ER resident chaperones. In addition, ATF6α(373) up-regulated ERdj3 (also known as HEDJ), an ER chaperone cofactor that has been identified as an XBP1 target ([@bib17]) ([Fig. 1](#fig1){ref-type="fig"} A). The XBP1(U) retroviral vector yielded the ∼30-kD pXBP1(U) and no detectable pXBP1(S), whereas the XBP1(S) virus exclusively yielded the ∼54-kD pXBP1(S). Cells transduced with XBP1(S), but not XBP1(U), exhibited increased levels of ERdj3 and BiP ([Fig. 1](#fig1){ref-type="fig"} A). These data demonstrate that ATF6α(373), XBP1(U), and XBP1(S) all functioned as predicted upon enforced expression in NIH-3T3 cells.

![**Phospholipid synthesis in NIH-3T3 fibroblasts retrovirally transduced with UPR transcriptional activators.** NIH-3T3 cells were transduced with the indicated pBMN-I-GFP retroviral vectors. (A) At 48 h after transduction, cells were harvested and equivalent amounts of cell lysate protein were resolved by standard SDS-PAGE under reducing conditions. Chemiluminescent immunoblotting was performed. A nonspecific band just below the position of pXBP1(S) was detected by the anti-XBP1 antibody. Calnexin served as a loading control. (B) Cells were metabolically labeled with \[^3^H\]choline for 2 h, a labeling interval in which \[^3^H\]choline is incorporated exclusively into PtdCho. The amount of radiolabel present in cellular lipid extracts was normalized as cpm/10^5^ cells and was plotted as the mean ± SD (*n* = 3; asterisk denotes P = 0.002 for comparison of XBP1(S) to empty vector). (C) Cells were harvested and total cellular mass of PtdCho, PtdEtn, and cholesterol was determined by flame ionization. Superscript a: average of triplicate determinations from two independent experiments (*n* = 6) ± SD. Superscript b: control NIH-3T3 values set at 100% for comparison.](200406136f1){#fig1}

In contrast to ATF6α(373) and XBP1(U), enforced expression of XBP1(S) resulted in a large (approximately fourfold) increase in PtdCho synthesis ([Fig. 1](#fig1){ref-type="fig"} B). Furthermore, the total amount of both PtdCho and phosphatidylethanolamine (PtdEtn), also a major lipid in intracellular membranes ([@bib18]), was increased approximately twofold in XBP1(S)-transduced cells. However, the mass of cholesterol, most prevalent in the plasma membrane, was unchanged ([Fig. 1](#fig1){ref-type="fig"} C). Therefore, XBP1(S) has the capacity to mediate substantial increases in phospholipids that constitute the membranes of intracellular organelles like the ER. It is important to note that the yeast UPR has also been implicated in lipid metabolism ([@bib5]).

Electron microscopy revealed that XBP1(S)-transduced cells contained an increased number of intracellular membrane--bound structures that were frequently studded with ribosomes, indicating their identity as RER ([Fig. 2](#fig2){ref-type="fig"} A). Indeed, the surface area and volume of RER were significantly increased in XBP1(S)-transduced cells, 2.5- and 3.4-fold, respectively ([Fig. 2](#fig2){ref-type="fig"} B). Immunofluorescence microscopy demonstrated that KDEL-containing proteins were distributed throughout the cytoplasm of XBP1(S)-transduced cells ([Fig. 2](#fig2){ref-type="fig"} C), consistent with an overall increase in the amount of ER. In addition, XBP1(S) induced a 44% increase in cell size (empty vector cells, 103.9 ± 1.8 μm^2^; XBP1(S) cells, 149.8 ± 2.5 μm^2^). Cells overexpressing XBP1(S) exhibited a slower rate of proliferation 24 h after transduction, but their viability was not affected through 48 h. Importantly, while this manuscript was under review, [@bib23] reported that XBP1(S) can mediate increased cell size and expansion of intracellular organelles including the ER, thereby corroborating our findings.

![**Microscopy analysis of the ER.** (A) At 48 h after transduction with the indicated retroviral vectors, thin sections were prepared from NIH-3T3 cells and examined by transmission EM. Representative micrographs of increasing magnification (from top to bottom) are shown with scale bar (1 μm) in top right corner: middle panels, arrow indicates representative ER; bottom panels, arrow indicates membrane-bound ribosomes. N, nucleus. (B) Stereological analysis of RER volume (top) and RER surface area (bottom) was performed on electron micrographs and the mean ± SEM are plotted (*n* = 4 stereological sets with 2--16 micrographs per set; \*, P \< 0.01). (C) Immunofluorescence analysis (using anti-KDEL mAb) and confocal microscopy was performed on NIH-3T3 cells grown on coverslips and transduced with the indicated retroviral vectors for 48 h.](200406136f2){#fig2}

Synthesis of XBP1(S) can also be elicited by ER stress-inducing agents such as the glycosylation inhibitor tunicamycin. In a series of experiments, we observed a trend toward a small increase (∼20%) in PtdCho biosynthesis within 3 to 4 h of tunicamycin treatment, but this was not sustained in a statistically significant fashion for longer intervals (unpublished data). Perhaps gross inhibition of protein folding in the ER and/or complete UPR activation in cells subjected to pharmacologic agents that poison the ER is not compatible with increased phospholipid biosynthesis.

Effect of XBP1(S) on the cytidine diphosphocholine pathway of PtdCho biosynthesis
---------------------------------------------------------------------------------

The predominant pathway for PtdCho biosynthesis in mammalian cells is the cytidine diphosphocholine (CDP-choline) or Kennedy pathway ([@bib18]). First, choline kinase (CK) phosphorylates choline in the presence of ATP to yield phosphocholine. Second, choline cytidylyltransferase (CCT) converts phosphocholine to CDP-choline in the presence of CTP, and this is considered to be the rate-limiting step in the CDP-choline pathway ([@bib18]). Third, cholinephosphotransferase 1 (CPT1) transfers the phosphocholine moiety of CDP-choline to DAG, producing PtdCho. This final step can also be catalyzed by choline/ethanolaminephosphotransferase (CEPT1), a bifunctional enzyme that can synthesize both choline- and ethanolamine-containing phospholipids. Here, we refer to the activities of CPT1 ([@bib12]) and CEPT1 ([@bib11]) collectively as CPT activity. In XBP1(S)-transduced cells, CK activity was unchanged ([Fig. 3](#fig3){ref-type="fig"} A), CCT activity increased ∼30% ([Fig. 3](#fig3){ref-type="fig"} B), and CPT activity elevated approximately fivefold ([Fig. 3](#fig3){ref-type="fig"} C). Remarkably similar to these data, increased PtdCho biosynthesis in lipopolysaccharide-stimulated splenic B cells was previously shown to correlate with unchanged CK activity, a small increase in CCT activity, and an approximately sixfold increase in CPT activity ([@bib21]). Therefore, it follows that XBP1(S) might mediate the increased synthesis of phospholipids necessary for ER biogenesis as B cells transition into high-rate antibody secretion.

![**Enzymatic activities in the CDP-choline pathway of PtdCho synthesis.** The relative activities of CK, CCT, and CPT, which constitute the CDP-choline pathway of PtdCho biosynthesis (right side of figure), were determined using lysates or microsomes prepared from NIH-3T3 cells (▪), or NIH-3T3 cells transduced with XBP1(S) (•) or empty vector (○). The rates of production of phosphocholine (P-Choline), CDP-Choline, and PtdCho were compared as a function of total protein in each assay. (A) Data for CK are averaged from triplicate determinations and are representative of two independent experiments. (B) Data for CCT are averaged from five determinations obtained in two independent experiments. (C) Data for CPT are averaged from duplicate determinations and are representative of three independent experiments.](200406136f3){#fig3}

There are three isoforms of CCT: α, β2, and β3. CCTα is ubiquitously expressed, whereas the β isoforms exhibit tissue-specific expression that is ∼10-fold lower compared with CCTα ([@bib15]). Quantitative real-time RT-PCR revealed no change in transcript levels for any of the CCT isoforms in XBP1(S)-transduced cells ([Fig. 4](#fig4){ref-type="fig"} A). Likewise, Northern blotting revealed no change in the steady-state levels of *CPT1* and *CEPT1* transcripts ([Fig. 4](#fig4){ref-type="fig"} B). These data suggest that enforced expression of XBP1(S) leads to post-transcriptional and/or post-translational regulation of the CCTα and CPT1/CEPT1 enzymes, thereby augmenting their activities and increasing synthesis of PtdCho ([Fig. 5](#fig5){ref-type="fig"}).

![**Expression of enzymes that function in the CDP-choline pathway of PtdCho synthesis.** Total RNA was prepared from NIH-3T3 fibroblasts harvested at 24 and 48 h after transduction with the indicated retroviral vectors. (A) The relative levels of expression of the *CCT*α, *β2*, and *β3* isoform cDNAs at the 48-h interval were measured by quantitative real-time PCR. The amount of target RNA was normalized to the endogenous *GAPDH* reference and related to the amount of target *CCT*α in NIH-3T3, which was set as the calibrator at 1.0 (superscript a). The mean ± SD (superscript b) of triplicate determinations is shown. (B) Northern blot analysis using ^32^P-labeled cDNA probes specific for *CEPT1* and *CPT1*, the two genes encoding enzymes possessing CPT activity; *ERdj3*, a known XBP1 target as a positive control; and *γ-actin* as a loading control.](200406136f4){#fig4}

![**A model for how XBP1 links the UPR to ER biogenesis.** In response to increased demand on the protein folding capacity of the ER, UPR-mediated splicing of *XBP1* mRNA yields the XBP1(S) transcriptional activator. We propose that XBP1(S) induces expression of unknown gene products that lead to an increase in CCT activity and a large increase in CPT activity, thereby augmenting synthesis of PtdCho. Increased production of PtdCho, the major phospholipid of the ER membrane, is critical for expansion of the ER compartment.](200406136f5){#fig5}

CCTα is an amphitropic enzyme as it transitions from a soluble form, largely sequestered in the nucleus, into a more active form associated with ER membranes ([@bib4]). Conversion of CCTα into the membrane-associated form correlates with dephosphorylation of serine residues near its carboxy terminus, and this influences its affinity for membranes ([@bib18]). Thus, there are a number of steps at which an XBP1(S)-regulated gene product might modulate CCTα activity. Both CPT1 and CEPT1 contain an estimated seven membrane-spanning helices and are predicted to reside in the ER membrane ([@bib11]; [@bib12]), but very little is known concerning control of their respective activities. Perhaps XBP1(S) regulates expression of an allosteric modulator or a cofactor that enhances the stability of CPT1 and/or CEPT1.

Summary
-------

Our data regarding XBP1(S) provide the first example of a transcription factor being sufficient to induce phospholipid biosynthesis and ER expansion in mammalian cells. Whether the expanded ER in XBP1(S)-transduced cells is properly organized and fully functional is under investigation. We propose that in a physiologic UPR, the IRE1-XBP1 pathway regulates synthesis of phospholipids according to cellular needs for ER membrane components ([Fig. 5](#fig5){ref-type="fig"}). Interestingly, inhibition of PtdCho biosynthesis via a thermosensitive mutation in the CCT enzyme has been correlated with UPR activation ([@bib26]), providing further evidence that the UPR might provide a means to rapidly respond to an increased need for phospholipids. Coordinating induction of phospholipid biosynthesis with up-regulated expression of ER resident proteins would allow the mammalian UPR to both build and equip the ER.

Materials and methods
=====================

Plasmids
--------

pBMN-I-GFP (Dr. G. Nolan, Stanford University, Palo Alto, CA) encodes a bicistronic mRNA with a GFP cassette 3′ of the internal ribosomal entry site (I). pBMN-hATF6(373)-I-GFP encodes aa 1--373 of human ATF6α ([@bib29]). pBMN-hXBP1(U)-I-GFP encodes full-length human XBP1 not modified by UPR-mediated splicing. pBMN-hXBP1(S)-I-GFP encodes full-length human XBP1 generated by UPR-mediated splicing.

Cell culture and retroviral transduction
----------------------------------------

NIH-3T3 fibroblasts and Phoenix-Eco cells (Dr. G. Nolan) were maintained in DME ([@bib7]). Ecotropic retroviruses were produced using Phoenix-Eco packaging cells ([@bib8]) and pBMN plasmids. Cells were transduced with retroviruses ([@bib2]) with ≥95% efficiency, as measured by GFP fluorescence using a FACSCalibur flow cytometer (BD Biosciences). Tunicamycin (Sigma-Aldrich) was used at 0.5 μg/ml.

Immunoblotting and Northern blotting
------------------------------------

Chemiluminescent immunoblotting of BiP, XBP1, and calnexin was performed as described previously ([@bib7]). The ERdj3 antisera was provided by Dr. Linda Hendershot (St. Jude Children\'s Research Hospital, Memphis, TN). Rabbit anti--mouse ERp72 antibody (SPA-720; Stressgen Biotechnologies) and mouse anti-β actin mAb (clone AC-15; Sigma-Aldrich) were purchased. Northern blotting was performed as described previously ([@bib7]). Probes used in this work are described in the online supplemental material.

Detection of CCT isoform mRNAs by real-time PCR
-----------------------------------------------

Quantitative real-time PCR of the *CCT*α, *β2*, and *β3* isoform cDNAs was performed as described previously ([@bib16]). For details, see online supplemental material.

Analysis of PtdCho synthesis
----------------------------

Cells were cultured for 2 h at 37°C in DME containing 2 μCi/ml methyl\[^3^H\]choline chloride (81 Ci/mmol; Amersham Biosciences). In tunicamycin experiments, labeling was performed during the final 2 h of treatment. After labeling, cells were washed with cold PBS and scraped in methanol/water (2:0.8, vol/vol). Lipids were extracted as described previously ([@bib1]). Radiolabel incorporated into chloroform-soluble metabolites was determined by scintillation spectroscopy. The organic phase was subjected to TLC in chloroform/methanol/water (65:35:4, vol/vol/vol) to verify that detectable radioactivity was present exclusively in PtdCho.

Phospholipid mass determinations
--------------------------------

Frozen cell pellets (2 × 10^7^ cells) were thawed on ice and resuspended in 1 ml of water. The total volume was measured and a 100-μl aliquot was removed for protein determination. The remainder of the lysate was extracted as described previously ([@bib1]). Lipids were detected by flame ionization using an Iatroscan instrument (Iatron Laboratories) with PEAK SIMPLE software (SRI Instruments). Peaks were identified by comigration with authentic standards. PtdCho, PtdEtn, and cholesterol mass were calculated using standard curves for each prepared with either the polar lipid (no. 1127) or the neutral lipid (no. 1129) mixture (Matreya, Inc.). For details, see online supplemental material.

CK, CCT, and CPT assays
-----------------------

Pelleted frozen cells (2 × 10^7^ cells) were used for assays of CK and CCT enzymatic activity as described previously ([@bib19], [@bib20]). CPT activity was assessed as described previously ([@bib11]) using microsomes prepared from frozen cell pellets (2 × 10^7^ cells). The assays were linear through the time of incubation at all protein concentrations. For details, see online supplemental material.

Immunofluorescence microscopy
-----------------------------

NIH-3T3 cells were seeded on glass coverslips in 60-mm dishes. At 48 h after transduction, cells were fixed on coverslips with 95% ethanol/5% acetic acid for 10 min at −20°C, blocked with PBS containing 5% FCS at RT, and then stained with mouse anti-KDEL mAb (SPA-827; StressGen Biotechnologies) or mouse IgG (Southern Biotechnology Associates) as an isotype control, followed by biotinylated goat anti--mouse IgG (Southern Biotechnology Associates) and R-phycoerythrin--conjugated streptavidin (Molecular Probes, Inc.). Coverslips were mounted in ProLong Antifade (Molecular Probes, Inc.) and were examined on a confocal microscope (LSM-510; Carl Zeiss MicroImaging, Inc.). Images were assessed using the LSM Browser (Carl Zeiss MicroImaging, Inc.) and were processed using Adobe Photoshop software.

Electron microscopy
-------------------

Retrovirally transduced NIH-3T3 cells were trypsinized, pelleted by centrifugation, fixed in cacodylate buffer containing 4% glutaraldehyde, and washed in cacodylate buffer. Cells were then postfixed with 1% osmium tetroxide prepared in cacodylate buffer, dehydrated by sequential extraction with graded concentrations of ethanol from 25 to 100%, and embedded in Embed 812 resin. Thin sections were cut on an ultramicrotome (Reichert), mounted on nickel grids, stained with saturated uranyl acetate and Reynolds lead citrate, and examined at 2,500, 8,000, and 20,000× at RT using a transmission electron microscope (model H-600; Hitachi). Images were captured on 35-mm film and were processed using Adobe Photoshop software.

Stereological measurements of RER and cell size determinations
--------------------------------------------------------------

Four independent stereological sets containing electron micrographs of empty vector-- and XBP1(S)-transduced cells at magnifications of 8,000 and 20,000 were analyzed. RER volume was measured by determining the volume fraction (V~v~) with a grid containing test points in the linear array (1-cm spacing). V~v~ is equal to the number of test points falling on RER divided by the number of test points falling on the containing space. RER surface area was calculated by determining the surface density (S~v~). S~v~ is equal to two times the number of line intersections with RER membrane, divided by the total length of line on the containing space ([@bib28]). Average cell size was determined from light microscopy analysis of thick sections using the Scion image program. The mean cell area (μm^2^) was determined in a minimum of 38 fields, and SEM was calculated.

Statistical analysis
--------------------

Both one-tailed and two-tailed independent *t* tests were used to compare test samples to controls. In all cases, both tests were in agreement. P values in figure legends correspond to results of one-tailed *t* tests.

Online supplemental material
----------------------------

Fig. S1 shows flow cytometric analysis of GFP expression in NIH-3T3 cells transduced with pBMN-I-GFP retroviral vectors encoding either ATF6α(373), XBP1(U) or XBP1(S). Details are provided for: detection of CCT isoform mRNAs by real-time PCR; northern hybridization probes; assays for enzymatic activities of CK, CCT, and CPT; phospholipid mass determinations. Online supplemental material available at <http://www.jcb.org/cgi/content/full/jcb.200406136/DC1>.
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